InvestorsHub Logo
Followers 0
Posts 51
Boards Moderated 0
Alias Born 04/12/2009

Re: None

Friday, 12/25/2009 11:24:04 PM

Friday, December 25, 2009 11:24:04 PM

Post# of 5645
The royalties from the recent FDA approval of CIMZIA http://www.ucb.com for moderate to severe rheumatoid arthritis (RA) in adults will be substantial, considering the aging population and projections that the rheumatoid arthritis market is expected to more than double in value to $27 Billion by 2015.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XOMA News